CGT

1,155개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,155 programs
CGTLimited DatastaleWuerzburg University HospitalPhase 2

SLAMF7 CAR-T (SLAMF7 CAR-T)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleMedigen Biotechnology Corporati…Phase 2

SLOG + Allogeneic NK cell (SLOG + Allogeneic NK cell)

Pancreatic Carcinoma Stage II; Cholangiocarcinoma Resectable · Pancreatic Carcinoma Stage II

#PancreaticCarcinomaStageII#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Simnova Biotechnology …Phase 1

SNC-109 CAR-T Cells (SNC-109 CAR-T Cells)

Recurrent Glioblastoma Multiforme · Recurrent Glioblastoma Multiforme

#RecurrentGlioblastomaMultiforme#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleSynthekinePhase 1

SYNCAR-001 (SYNCAR-001)

CLL/SLL; NHL · CLL/SLL

#CLLSLL#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleGuangdong ProCapZoom Bioscience…Preclinical

SZ003 CAR-NK (SZ003 CAR-NK)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastalePeking UniversityPhase 1

ScTIL injection and B lymphocytes adjuvant (ScTIL injection and B lymphocytes adjuvant)

Digestive System Malignant Solid Tumors · Digestive System Malignant Solid Tumors

#DigestiveSystemMalignantSolidTum#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleVittoria BiotherapeuticsPhase 1

Senza5 CART5 (Senza5 CART5)

T Cell Non-Hodgkin Lymphoma · T Cell Non-Hodgkin Lymphoma

#TCellNon-HodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleZhujiang HospitalPhase 1

Sequential Treatment With different CART (Sequential Treatment With different CART)

Therapy Related Leukemia · Therapy Related Leukemia

#TherapyRelatedLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleInstitute of Hematology & Blood…Phase 1

Sup19 CAR-T (Sup19 CAR-T)

B-Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia/Lymphoma · B-Acute Lymphoblastic Leukemia

#B-AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

B7-H3-positive Relapsed/ Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting FLT3 chimeric antigen receptor (T cell injection targeting FLT3 chimeric antigen receptor)

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

T cells modified with RNA anti -cMET CAR (T cells modified with RNA anti -cMET CAR)

Malignant Melanoma; Breast Cancer · Malignant Melanoma

#MalignantMelanoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleUniversidad Autonoma de MadridPhase 2

T memory cells and NK cells (T memory cells and NK cells)

Corona Virus Infection · Corona Virus Infection

#CoronaVirusInfection#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShanghai GeneChem Co., Ltd.Phase 2

TAI-GPC3-CART cells (TAI-GPC3-CART cells)

Carcinoma, Hepatocellular · Carcinoma, Hepatocellular

#CarcinomaHepatocellular#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai GeneChem Co., Ltd.Phase 1

TAI-meso-CART (TAI-meso-CART)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 1

TGFBR-2 KO CD70 CAR NK (TGFBR-2 KO CD70 CAR NK)

Clear Cell Carcinoma; Phase 1 · Clear Cell Carcinoma

#ClearCellCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 1

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

Breast Cancer · TROP2

#TROP2#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 1

TGFβR-KO CAR-EGFR T Cells (TGFβR-KO CAR-EGFR T Cells)

Solid Tumor, Adult; EGFR Overexpression · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleShanghai Tongji Hospital, Tongj…Phase 1

TH-CART-027 (TH-CART-027)

Solid Tumors · Solid Tumors

#SolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleNantes University HospitalPhase 2

nivolumab (Opdivo, TIL + IL-2 + Nivolumab)

Melanoma · Melanoma

#Melanoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active

51 / 58 pages

← PreviousNext →